secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0001654954-22-010528
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience shareholders elect four directors, ratify BDO as auditor
------------------------------------------------------------------------

- Elected Maggiore (Class I), Masterson (Class II), Payne and Cornell (Class III) to board with 3.4M+ votes for each.
- Ratified BDO USA as auditor for FY2022 with 6,067,848 for, 139,397 against.
- Advisory vote on executive compensation passed with 3,805,069 for, 125,306 against.
- Turnout: 6,208,928 shares represented (approx 66% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495422010528/0001654954-22-010528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495422010528/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-010528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer